ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.57
0.23%
US Tech 100
19,288.80
-0.62%
S&P 500
5,473.17
-0.25%
US Dollar vs CAD
1.36764
-0.06%
Bitcoin
64,530.81
-0.45%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sonnet BioTherapeutics Holdings Inc (SONN)

  7. Sonnet BioTherapeutics Holdings Inc (SONN) News

Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

NASDAQ
1.04
-0.49
(-32.03%)
Closed June 21 3:00PM
Delayed by 15 minutes
1.07
0.03
(2.88%)
After Hours: 6:27PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

SONN News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
May 22 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
May 20 2024
SONN (-32.03%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
May 16 2024
SONN (-32.03%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
May 16 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
May 14 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
May 14 2024
SONN (-32.03%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 14 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
March 11 2024
SONN (-32.03%)

Form 8-K - Current report
Edgar (US Regulatory)
February 14 2024
SONN (-32.03%)

SONN Discussion

View Posts
BooDog BooDog 2 months ago
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 3 months ago
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 3 months ago
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 3 months ago
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 3 months ago
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 3 months ago
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 3 months ago
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 3 months ago
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 3 months ago
Riding free again.
👍️0
Monksdream Monksdream 4 months ago
SONN under $2
👍️0
crowin crowin 4 months ago
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 4 months ago
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 5 months ago
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 6 months ago
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 8 months ago
SONN new 52 week low
👍️0
BooDog BooDog 8 months ago
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 8 months ago
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 8 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 9 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 9 months ago
SONN new 52 week low
👍️0
Monksdream Monksdream 9 months ago
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 9 months ago
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 9 months ago
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 9 months ago
You worry about you ok?
👍️0
Monksdream Monksdream 9 months ago
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 9 months ago
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 9 months ago
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 9 months ago
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 9 months ago
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 9 months ago
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0
Monksdream Monksdream 9 months ago
SONN new 52 week low
👍️0
Golden Cross Golden Cross 9 months ago
Might be a short play here now
👍️0
Golden Cross Golden Cross 9 months ago
Very true.....
👍️0
antman antman 10 months ago
...During his testimony, Elon Musk called short selling “a means for, in my opinion, bad people on Wall Street to steal money from small investors.”
👍️0
tw0122 tw0122 10 months ago
Biotech CEOs are mostly Wall Street whores they get compensated to short there own companies as it’s much more lucrative. They take on that toxic financing do reverse splits as part of their regular routine. Take MULN CEO for example he has no scruples or morals nor does he hide his screwing over shareholders.
As far as trading you play the post reverse splits at the right time with the low float and that is where the loot is made.
Wall Street casino.
👍️0
valleybenedetto valleybenedetto 10 months ago
CEO is an incompetent whore. Stock ran to 1.20 . Instead of letting it sit for 10 days and regain compliance he jammed an offering down and screwed everyone.
👍️0
antman antman 10 months ago
I guess the shorts just crush all these companies and force them to do rollbacks
👍️0
Golden Cross Golden Cross 10 months ago
Don't see the vote not passing now
👍️0
Golden Cross Golden Cross 10 months ago
Nothing has gone right since the offering.. Time for a turnaround here... loading up
👍️0
Golden Cross Golden Cross 10 months ago
Yep
👍️0
govprs govprs 10 months ago
Did you see the letter to shareholders?
👍️0
Golden Cross Golden Cross 10 months ago
needs something here
👍️0
TimeFades TimeFades 10 months ago
See if she can start a new uptrend
👍️0
tw0122 tw0122 10 months ago
Nice to see the new Fibonacci targets going the other way now
👍️0
Golden Cross Golden Cross 10 months ago
$SONN Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
https://www.accesswire.com/773690/Sonnet-BioTherapeutics-Provides-Fiscal-Year-2023-Third-Quarter-Business-and-Earnings-Update
👍️0
limer814 limer814 10 months ago
$SONN Whoever John Markey is ,he knows something we don't. Another 13g filed this am . He is up to 4.1m shares now..I'm still holding pic.twitter.com/AW4hN0Secj— Keith Rah (@keith_rah) August 7, 2023
👍️0
starkd748 starkd748 11 months ago
Around .27 gap fill....Glad I read charts prs and filings about share purchases don't mean squat
👍️0
surf1944 surf1944 11 months ago
https://stockcharts.com/h-sc/ui?s=sonn&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/sonn/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/sonn/opinion
👍️0
Golden Cross Golden Cross 11 months ago
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
https://www.accesswire.com/771212/Sonnet-BioTherapeutics-to-Present-at-the-2023-BTIG-Virtual-Biotechnology-Conference
👍️0
Golden Cross Golden Cross 11 months ago
That didn't look good
👍️0

Your Recent History

NASDAQ
SONN
Sonnet BioTherapeutics
NYSE
NVRI
Enviri
LSE
MF73
Barclays 26
NASDAQ
SELF
Global Self Storage
BMF
OC1N28
OC1N28 - Julho 2028
DBI
I8NM
IN XTK 2 IBEUGBYP
ASX
MTSKOP
EU
M843S
M843S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved